Opiant Pharmaceuticals to Report Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 11, 2022

Rhea-AI Summary

Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) will report its financial results for Q2 2022 on August 11, 2022, after market close. A conference call with management is scheduled for the same day at 4:30 p.m. ET, accessible via U.S. and international lines. Opiant, known for its NARCAN^® Nasal Spray, focuses on developing treatments for addiction and drug overdose. For further details, visit www.opiant.com.

Positive

• Company scheduled to report financial results on August 11, 2022, which could highlight growth and operational performance.

Negative

• None.

SANTA MONICA, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today announced it will report its financial results for the second quarter ended June 30, 2022, after the financial markets close on Thursday, August 11, 2022.  

The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Thursday, August 11, 2022. To access the call, please dial 1-877-407-0792 in the U.S. or 1-201-689-8263 outside the U.S. and provide the conference ID number: 13730815. To access the live webcast, please visit https://viavid.webcasts.com/starthere.jsp?ei=1556372&tp_key=6cb19180df. Following the live webcast, an archived version of the call will be available on the website.

Thursday August 11 @ 4:30 pm ET

Domestic:	1-877-407-0792
International:	1-201-689-8263
Conference ID:	13730815
Webcast:	https://viavid.webcasts.com/starthere.jsp?ei=1556372&tp_key=6cb19180df

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN^® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com.

For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com

FAQ

When will Opiant Pharmaceuticals report its Q2 2022 financial results?

Opiant Pharmaceuticals will report its Q2 2022 financial results on August 11, 2022.

What time is the Opiant Pharmaceuticals conference call scheduled?

The conference call for Opiant Pharmaceuticals is scheduled for 4:30 p.m. ET on August 11, 2022.

How can I access Opiant Pharmaceuticals' conference call?

To access the conference call, dial 1-877-407-0792 in the U.S. or 1-201-689-8263 internationally and provide the conference ID: 13730815.

What is the ticker symbol for Opiant Pharmaceuticals?

The ticker symbol for Opiant Pharmaceuticals is OPNT.